Idesolide inhibits the adipogenic differentiation of mesenchymal cells through the suppression of nitric oxide production

Jun Ha Hwang, Sung Ah Moon, Cham Han Lee, Mi Ran Byun, A. Rum Kim, Mi Kyung Sung, Hyun Jin Park, Eun Sook Hwang, Sang Hyun Sung, Jeong-Ho Hong

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Obesity is a major health problem worldwide and can increase the risk for several chronic diseases, including diabetes and cardiovascular disease. In this study, we screened small compounds isolated from natural products for the development of an anti-obesity drug. Among them, idesolide, a spiro compound isolated from the fruits of Idesia polycarpa Maxim, showed a significant suppression of the adipogenic differentiation in mesenchymal cells, as indicated by the decrease in fat droplets and expression of adipogenic marker genes such as aP2 and adiponectin. Idesolide inhibits the PPARλ-mediated gene transcription in a dose-dependent manner, revealed by luciferase reporter gene assay.During adipogenic differentiation, idesolide inhibits nitric oxide production through the suppression of iNOS expression, and the increased adipogenic differentiation by arginine, the substrate for NOS, is significantly inhibited by idesolide, suggesting that the inhibition of nitric oxide production plays a major role in idesolide-induced adipogenic suppression. Taken together, the results reveal that idesolide has anti-adipogenic activity and highlight its potential in the prevention and treatment of obesity.

Original languageEnglish
Pages (from-to)218-223
Number of pages6
JournalEuropean Journal of Pharmacology
Volume685
Issue number1-3
DOIs
Publication statusPublished - 2012 Jun 15

Fingerprint

Cell Differentiation
Nitric Oxide
Spiro Compounds
Obesity
Anti-Obesity Agents
Peroxisome Proliferator-Activated Receptors
Adiponectin
Biological Products
Luciferases
Reporter Genes
Genes
Arginine
idesolide
Fruit
Chronic Disease
Cardiovascular Diseases
Fats

Keywords

  • Adipogenic differentiation
  • Idesolide
  • Nitric oxide
  • Obesity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Idesolide inhibits the adipogenic differentiation of mesenchymal cells through the suppression of nitric oxide production. / Hwang, Jun Ha; Moon, Sung Ah; Lee, Cham Han; Byun, Mi Ran; Kim, A. Rum; Sung, Mi Kyung; Park, Hyun Jin; Hwang, Eun Sook; Sung, Sang Hyun; Hong, Jeong-Ho.

In: European Journal of Pharmacology, Vol. 685, No. 1-3, 15.06.2012, p. 218-223.

Research output: Contribution to journalArticle

Hwang, Jun Ha ; Moon, Sung Ah ; Lee, Cham Han ; Byun, Mi Ran ; Kim, A. Rum ; Sung, Mi Kyung ; Park, Hyun Jin ; Hwang, Eun Sook ; Sung, Sang Hyun ; Hong, Jeong-Ho. / Idesolide inhibits the adipogenic differentiation of mesenchymal cells through the suppression of nitric oxide production. In: European Journal of Pharmacology. 2012 ; Vol. 685, No. 1-3. pp. 218-223.
@article{8c7e0060f79844abb6e458b6182b8fb0,
title = "Idesolide inhibits the adipogenic differentiation of mesenchymal cells through the suppression of nitric oxide production",
abstract = "Obesity is a major health problem worldwide and can increase the risk for several chronic diseases, including diabetes and cardiovascular disease. In this study, we screened small compounds isolated from natural products for the development of an anti-obesity drug. Among them, idesolide, a spiro compound isolated from the fruits of Idesia polycarpa Maxim, showed a significant suppression of the adipogenic differentiation in mesenchymal cells, as indicated by the decrease in fat droplets and expression of adipogenic marker genes such as aP2 and adiponectin. Idesolide inhibits the PPARλ-mediated gene transcription in a dose-dependent manner, revealed by luciferase reporter gene assay.During adipogenic differentiation, idesolide inhibits nitric oxide production through the suppression of iNOS expression, and the increased adipogenic differentiation by arginine, the substrate for NOS, is significantly inhibited by idesolide, suggesting that the inhibition of nitric oxide production plays a major role in idesolide-induced adipogenic suppression. Taken together, the results reveal that idesolide has anti-adipogenic activity and highlight its potential in the prevention and treatment of obesity.",
keywords = "Adipogenic differentiation, Idesolide, Nitric oxide, Obesity",
author = "Hwang, {Jun Ha} and Moon, {Sung Ah} and Lee, {Cham Han} and Byun, {Mi Ran} and Kim, {A. Rum} and Sung, {Mi Kyung} and Park, {Hyun Jin} and Hwang, {Eun Sook} and Sung, {Sang Hyun} and Jeong-Ho Hong",
year = "2012",
month = "6",
day = "15",
doi = "10.1016/j.ejphar.2012.04.018",
language = "English",
volume = "685",
pages = "218--223",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Idesolide inhibits the adipogenic differentiation of mesenchymal cells through the suppression of nitric oxide production

AU - Hwang, Jun Ha

AU - Moon, Sung Ah

AU - Lee, Cham Han

AU - Byun, Mi Ran

AU - Kim, A. Rum

AU - Sung, Mi Kyung

AU - Park, Hyun Jin

AU - Hwang, Eun Sook

AU - Sung, Sang Hyun

AU - Hong, Jeong-Ho

PY - 2012/6/15

Y1 - 2012/6/15

N2 - Obesity is a major health problem worldwide and can increase the risk for several chronic diseases, including diabetes and cardiovascular disease. In this study, we screened small compounds isolated from natural products for the development of an anti-obesity drug. Among them, idesolide, a spiro compound isolated from the fruits of Idesia polycarpa Maxim, showed a significant suppression of the adipogenic differentiation in mesenchymal cells, as indicated by the decrease in fat droplets and expression of adipogenic marker genes such as aP2 and adiponectin. Idesolide inhibits the PPARλ-mediated gene transcription in a dose-dependent manner, revealed by luciferase reporter gene assay.During adipogenic differentiation, idesolide inhibits nitric oxide production through the suppression of iNOS expression, and the increased adipogenic differentiation by arginine, the substrate for NOS, is significantly inhibited by idesolide, suggesting that the inhibition of nitric oxide production plays a major role in idesolide-induced adipogenic suppression. Taken together, the results reveal that idesolide has anti-adipogenic activity and highlight its potential in the prevention and treatment of obesity.

AB - Obesity is a major health problem worldwide and can increase the risk for several chronic diseases, including diabetes and cardiovascular disease. In this study, we screened small compounds isolated from natural products for the development of an anti-obesity drug. Among them, idesolide, a spiro compound isolated from the fruits of Idesia polycarpa Maxim, showed a significant suppression of the adipogenic differentiation in mesenchymal cells, as indicated by the decrease in fat droplets and expression of adipogenic marker genes such as aP2 and adiponectin. Idesolide inhibits the PPARλ-mediated gene transcription in a dose-dependent manner, revealed by luciferase reporter gene assay.During adipogenic differentiation, idesolide inhibits nitric oxide production through the suppression of iNOS expression, and the increased adipogenic differentiation by arginine, the substrate for NOS, is significantly inhibited by idesolide, suggesting that the inhibition of nitric oxide production plays a major role in idesolide-induced adipogenic suppression. Taken together, the results reveal that idesolide has anti-adipogenic activity and highlight its potential in the prevention and treatment of obesity.

KW - Adipogenic differentiation

KW - Idesolide

KW - Nitric oxide

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84861348597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861348597&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2012.04.018

DO - 10.1016/j.ejphar.2012.04.018

M3 - Article

C2 - 22546224

AN - SCOPUS:84861348597

VL - 685

SP - 218

EP - 223

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -